« See This Open Innovation Review | Main | FDA Comments on Its Role in Rare Diseases & Orphan Drugs »

06/19/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133f180971d970b

Listed below are links to weblogs that reference Smart Kid Explains Orphan Drugs, Pricing and Profits:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Here's a link to an article from in-Pharma Technologist detailing Pfizer's new rare disease unit.
http://www.in-pharmatechnologist.com/Industry-Drivers/Pfizer-continues-on-rare-disease-path-with-new-R-D-unit?utm_source=RSS_text_news

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada